Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$4.56 - $6.61 $53,972 - $78,235
11,836 New
11,836 $61,000
Q4 2021

Feb 14, 2022

SELL
$11.49 - $22.0 $162,238 - $310,640
-14,120 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$16.35 - $23.4 $230,862 - $330,408
14,120 New
14,120 $263,000
Q4 2020

Feb 16, 2021

SELL
$20.81 - $30.55 $167,686 - $246,171
-8,058 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$17.5 - $30.23 $141,015 - $243,593
8,058 New
8,058 $244,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.